Tag: ASX:IMM
May 17, 2019
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma
Immutep (NASDAQ:IMMP, ASX:IMM) has announced data related to its Part B ongoing Phase I TACTI-mel clinical study of its lead... March 22, 2019